Brought to you by 
Glaucoma device company Sensimed gets CHF8mm in Series A
04 Jan 2008
Executive Summary
Ophthalmic monitoring device firm Sensimed AG grossed CHF8mm ($7mm) through its Series A financing co-led by Wellington Partners and Vinci Capital (Renaissance Technologies 2 fund) and including Blue Ocean Capital. A Wellington executive has joined the company's board.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Glaucoma device company Sensimed gets CHF8mm in Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice